Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H27N3O.ClH |
| Molecular Weight | 397.941 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C(CC1=NC(CC(C2=CC=CC=C2)C3=CC=CC=C3)=NO1)N4CCCCC4
InChI
InChIKey=ONTOFAWPPHNLML-UHFFFAOYSA-N
InChI=1S/C23H27N3O.ClH/c1-4-10-19(11-5-1)21(20-12-6-2-7-13-20)18-22-24-23(27-25-22)14-17-26-15-8-3-9-16-26;/h1-2,4-7,10-13,21H,3,8-9,14-18H2;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C23H27N3O |
| Molecular Weight | 361.48 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006909 Sources: https://www.ncbi.nlm.nih.gov/pubmed/340236 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17300686
Unknown
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:35:40 GMT 2025
by
admin
on
Mon Mar 31 21:35:40 GMT 2025
|
| Record UNII |
390WW7V7MZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Libexin
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | |||
|
213-567-6
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | |||
|
982-43-4
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | |||
|
m9124
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID00243511
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | |||
|
120507
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | |||
|
SUB15009MIG
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | |||
|
100000078851
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY | |||
|
390WW7V7MZ
Created by
admin on Mon Mar 31 21:35:40 GMT 2025 , Edited by admin on Mon Mar 31 21:35:40 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |